Background: Aortic stenosis shares some ethiopathological features with atherosclerosis and increasing evidence links Toll-like receptors (TLRs) to atherogenesis.
Introduction
Degenerative aortic stenosis, the most common cause of valve replacement in western countries, is a common disease in the elderly characterized by progressive calcification and increased valve thickness [1] . Valvular calcification is no longer considered a degenerative and passive process but an actively regulated process, the molecular mechanisms of which remain to be elucidated [1, 2] . Many studies have shown the role of atherogenic risk factors in valve calcification. In fact aortic stenosis shares some ethiopathological features with the atherosclerosis, like inflammatory cell infiltration, oxidized lipid deposition, and cytokine expression, although there are some differentiating features [2, 3] . At the molecular level, inflammatory mediators, growth factors, matrix metalloproteinases, the renin-angiotensin system, and pro-osteogenic pathways have been shown to participate in valve disease pathogenesis [1, 2] , although a pharmacological target valuable for the development of therapies is still to be defined.
Toll-like receptors (TLRs), key players in the innate and adaptive immunity, have been associated to the pathogenesis of inflammatory diseases such as atherosclerosis [4] . TLRs are a family of transmembrane receptors involved in the recognition of conserved patterns from microbes, as well as danger-associated endogenous molecules [5] . To date several TLRs, 11 in humans, have been identified [5] . Cell-surface receptors include TLR4 that recognizes lipopolysaccharide present in Gram-negative bacteria, TLR2 and its co-receptors TLR1/TLR6, which sense bacterial lipoproteins and lipoteichoic acid, TLR5 that recognizes bacterial flagellin, TLR11 that senses profilinglike molecules in parasites, and TLR10, the ligand of which remains unknown. Another subtype of receptors localized in the endosomal cell compartment include TLR3, that recognizes dsRNA, TLR9, that senses unmethylated CpG motifs present in viral and 5 bacterial genome and parasites, and TLR7, that binds ssDNA [5] . Upon stimulation, TLRs initiate intracellular signalling cascades that ultimately promote pro-inflammatory gene expression. All TLRs, but TLR3, induce MyD88-dependent activation of NF-B and MAPK cascades, while a MyD88-independent pathway, involving the induction of IFN-inducible genes, have been described to be triggered upon TLR3 and TLR4 activation [5] . Accumulating evidence links TLR activation to atherogenesis, especially TLR2 and TLR4, although new evidences support the involvement of viral receptors [4, 6] . Even more, the TLR4-D299G human polymorphism has been associated to lower risk of carotid atherosclerosis and increased risk of myocardial infarction [6] . More recently, a clinical study demonstrated that high expression of TLR2 on monocytes is a risk factor for atherogenesis, independent from other established risk factors [7] .
Cardiovascular cells such as cardiomyocytes, vascular smooth muscle and endothelial cells are known to express TLRs [8] . Moreover, aortic valve interstitial cells (AVICs), a prominent cell type in the heart valve leaflets that can undergo a phenotypic differentiation to osteoblast-like cells and play a role in valve calcification [9, 10] , have been described to express TLR4 and TLR2 [11] . Given the connection between TLR and the atherosclerosis process, which shares some pathophysiological features with aortic stenosis, and to better understand the molecular mechanisms underlying the valve disease, we explored the role of TLR activation in human AVICs isolated from surgically explanted stenotic and non-stenotic aortic valves. For that purpose, we evaluated TLR expression in cells from control and calcified stenotic valves, as well as TLR-coupled signalling cascade, and induction of pro-inflammatory mediators and calcification markers.
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Methods
Reagents
Collagenase type II and M199 medium were from Invitrogen (Carlsbad, CA). Bovine fetal serum and antibiotics were from Clonetics-Lonza (Walkersville, MD). E. coli LPS, bis-benzimide (DAPI), alkaline phosphatase (ALP) blue kit, and an anti--tubulin antibody were purchased from Sigma (St. Louis, MO). Pam 3 CSK4, CpG-ODN, and polyinosinic-polycytidylic acid (poly (I:C)) were from InvivoGen (San Diego, CA).
Antibodies against ERK, cyclooxigenase (COX)-2, and intercellular adhesion molecule (ICAM)-1 were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-JNK, anti-phospho-p38, and anti-phospho-Ser 536-pNF-B p65 form antibodies were from Cell Signaling (Danvers, MA). Anti-phospho-ERK antibody was from Promega (Madison, WI). TRIzol was from Life Technologies (Grand Island, NY). PE-conjugated anti-human TLR4, IgG2a-PE isotype control, and goat anti-mouse IgG-FITC antibodies were from eBioscience (San Diego, CA). Enhanced chemiluminiscence detection system was from Pierce (Rockford, IL). NF-κB SN50 was from Calbiochem (Darmstadt, Germany). PGE 2 immunoassay kit was from GE-Amersham (Buckinghamshire, United Kingdom). Cytokine antibody array V was from RayBiotech, Inc. (Norcross, GA). ALP Fluorometric Assay Kit was from Abcam (Cambridge, UK).
Patient selection
The study included 10 explanted heart valves from patients with degenerative aortic stenosis and indication for valve replacement (6 males/4 females, mean age 72.0 ± 7.1 7 years). Aortic valve area was 0.7 ± 0.2 cm², peak gradient 88 ± 22 mmHg and mean gradient 56 ± 15 mmHg. Control group consisted of 10 aortic valves from transplanted patients with valve disease excluded by echocardiography (8 males/2 females, mean age 59.3 ± 6.2 years). Diagnosis of the aortic valve lesion and indications for valve replacement and heart transplant was performed following European guidelines. All patients gave informed consent and Hospital Clínico Universitario Review Board approved the study, which complies with the Declaration of Helsinki.
Isolation and culture of human AVICs
After surgery, the aortic valves were dissected to eliminate non-valvular tissue, and calcium deposits in the case of stenotic valves. Cells were isolated with a method based on sequential digestion of valve leaflets with 2.5 mg/ml collagenase for 30 min at 37 ºC, and 0.8 mg/ml collagenase for 3 h at 37 ºC [11] . Then, cells were cultured in M199 media supplemented with penicillin G, streptomycin, amphotericin B and 10% serum.
For the experiments, AVICs from passages 3-6 were used. Before performing experiments, cells were cultured in low-serum media (M199 supplemented with antibiotics and 2% serum). α-SM-actin staining [12] revealed no apparent morphological differences in cells explanted from control and stenotic valves and confirmed that more than 95% cells were myofibroblast-like (data not shown). For calcification experiments, cells were cultured in conditioning medium (M199 supplemented with 10 mmol/l -glycerophosphate, 10 nmol/l vitamin D 3 , and 10 nmol/l dexamethasone) as previously described [13] 
Immunodetection of pNF-κB, MAP kinases, COX-2, and ICAM-1
TLR-activated cells were analyzed by Western blot as described earlier [14] .
Briefly, cells were lysed with TNE buffer (20 mmol/L Tris-HCl, pH 7.4, 150 mmol/L NaCl, 5 mmol/L EDTA, 0.01% NP-40, and a cocktail of protease and phosphatase inhibitors) for 10 min on ice. 50 g protein per lane was analyzed, and proteins were visualized using a chemiluminescence detection system. NF-B activation was measured using an anti-phospho-NF-B p65 antibody. MAP kinase activation was evaluated using phosphospecific antibodies for the phosphorylated forms of ERK, JNK, and p38 MAPK. Expression of pro-inflammatory molecules was detected with human COX-2 and ICAM-1 antibodies. Equal loading across the gel was confirmed using an anti--tubulin antibody.
ELISA for human prostaglandin (PG)-E 2
Supernatants from human AVICs stimulated with the corresponding TLR ligands for 8, 12 and 24 h were used to quantify PGE 2 secretion by an immunoassay kit following the manufacturer´s protocol. Absorbance was measured using a microplate reader Versamax (Molecular Devices, Sunnyvale, CA).
Analysis of cytokine expression levels by protein arrays
Supernatants from cells stimulated with corresponding ligand for 12 h at 37 ºC were analyzed with Human Cytokine Antibody Array V. Briefly, previously blocked membranes were incubated with supernatants for 2 h, later incubated with the primary biotin-conjugated antibody for 2 h, followed by incubation with HRP-conjugated streptavidin antibodies for 1 h. Chemiluminiscence detection was followed with
exposure to x-ray film. Densitometry of cytokine spots was analyzed by Image Quant TL software (Amersham, Buckinghamshire, UK).
ALP activity assay and staining
To evaluate ALP expression, cells were fixed with p-formaldehyde, stained with the ALP blue kit following manufacturer´s protocol, and photographed. For measuring ALP activity, cells were lysed with 20 mmol/L Tris-HCl, pH 8, 150 mmol/L NaCl, 0.2% NP-40, and a cocktail of protease and phosphatase inhibitors, as previously described [13] , the enzymatic activity was evaluated using a fluorometric assay kit, and results were expressed as pmol/min.h.
Statistical analysis
Results are expressed as mean SD. Data were analyzed by either unpaired t´ test using GraphPad Prism version 4 (San Diego, CA). Differences were considered statistically significant for a p < 0.05.
Results
Human AVICs from control valves express most of TLRs
To evaluate TLR gene expression in human AVICs, we quantified the TLR mRNA levels by real time RT-PCR. Experiments performed with n= 10 valves revealed that all
TLRs, but TLR8, are expressed in human AVICs, the TLR4 receptor being the most abundant subtype, with the others expressed at lower levels ( Fig. 1A) . Cells express receptors such as TLR2 and TLR4 (Fig. 1A ), consistent with a recent report [11] , as well as TLR2 co-receptors TLR1 and TLR6, and TLR5. Interestingly, cells also express endosomal receptors involved in sensing nucleic acids like TLR3, and to a lower extent TLR7 and TLR9 (Fig. 1A) .
Differential TLR mRNA expression in AVICs from stenotic and control valves
Next, we analyzed TLR gene expression in AVICs isolated from stenotic valves.
Similar TLR expression profiles, but differences in transcript levels, were observed in AVICs from stenotic as compared to control valves (Fig. 1A) . Quantitative analysis revealed an increase of TLR4 and TLR2 mRNA levels in stenotic as compared to control valves (TLR4: control 737.8 ± 122.9, stenotic 2163.0 ± 452.3; TLR2: control 53.8 ± 9.5, stenotic 101.2 ± 22.1), while no significant differences on TLR2 coreceptors TLR1 and TLR6 were observed. On the contrary, TLR5 levels were significantly diminished in stenotic valves (Fig. 1A) . As for endosomal receptors, TLR9
showed a significant lower expression in stenotic valves, while no statistically significant differences in TLR3 and TLR7 levels were observed in control and diseased valves (Fig. 1A) . Together, data show over-expression of TLR4 and TLR2, and down-regulation of TLR5 and TLR9 in AVICs from stenotic valves when compared to those from control valves.
Total cellular but not cell-surface TLR4 is higher in AVICS from stenotic valves than in control valves
To assess TLR4 protein expression, AVICs labelled with a fluorescent anti-TLR4
antibody were analyzed by flow cytometry. In experiments performed with control AVICs permeabilized with saponin, a single peak of fluorescence was observed, while two peaks with low and higher fluorescence intensity were observed in nonpermeabilized cells (Fig. 1B) , suggesting the existence of two populations of TLR4 and that most receptors are not expressed on the cell-surface but are internalized or have not yet located into the membrane. Likewise, AVICs from stenotic valves showed two distinct TLR4 populations (Fig. 1C) . When comparing the relative expression, the total cellular TLR4 was significantly higher in AVICs from stenotic as compared to control valves ( Fig. 1D ) consistent with quantitative RT-PCR results, while no significant differences in the number of cell-surface receptors were observed. Together, results suggest that most of TLR4 are not exposed to the cell-surface, being the total cellular, and not cell-surface, increased in AVICs from stenotic as compared to control valves.
TLR3, TLR2 and TLR4 agonists induce NF-κB and MAPK/p38 activation in AVICS from control and stenotic valves
Since TLR signalling promotes the activation of NF-κB and MAPK cascades [5] , and AVICS express functional TLR2 and TLR4 [11] , we assessed intracellular signalling of
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TLRs involved in the recognition of nucleic acids and compared with TLRs that sense bacterial patterns. For this purpose, cells were either stimulated with a TLR3 agonist, poly (I:C), a synthetic polymer of inosine that resembles the RNA of infectious viruses and stimulates the production of interferon, or a TLR9 agonist, CpG-ODN, an unmethylated sequence present in bacterial and viral DNA. In AVICs from control and stenotic valves, NF-κB p65 phosphorylation was observed after 20-60 min stimulation with poly (I:C) but not with CpG-ODN (Fig. 2, panels A-B) , consistent with the low expression of TLR9 in AVICs (Fig. 1A) . As for bacterial patterns, LPS and Pam 3 CSK4
stimulation induced NF-κB p65 phosphorylation in control AVICs ( Fig. 2A) , and similar results were observed with cells from diseased valves (Fig. 2B) . Next, we evaluated the activation of MAPK cascades by using phosphospecific antibodies.
Interestingly, a phosphorylated form of MAPK/p38, a kinase with an important role on inflammation, was detected 20-60 min upon stimulation with TLR3, TLR4, and TLR2 agonists (Fig. 2, panels A-B) . We also evaluated the MAPK/ERK pathway, known to play a crucial role in osteoblast differentiation and mineralization [15] , by measuring ERK1/ERK2 phosphorylation. Interestingly, AVICs from control and stenotic valves showed some degree of ERK phosphorylation in basal conditions (Fig. 2, panels A-B) ; being ERK2 the major phosphorylated form. Likewise, the MAPK/JNK cascade was already activated in resting cells (Fig. 2, panels A-B) ; being JNK2 the major phosphorylated form in AVICs. Together, results show that TLR3, TLR2, and TLR4
induce the activation of the NF-κB and MAPK/p38 pro-inflammatory pathways, in
AVICs from both stenotic and non-stenotic valves.
TLR3 activation promotes NF-κB-independent induction of pro-inflammatory molecules in AVICs from control and stenotic valves
Next, we evaluated TLR signalling at late times and the induction of proinflammatory molecules. Interestingly, poly (I:C), but not CpG, induced sustained NF-κB activation, since a phosphorylated form of NF-κB p65 was detected 12-24 h after stimulation of AVICs from control and stenotic valves (Fig. 3A) . Strikingly, poly (I:C) strongly induced the expression of the pro-inflammatory enzyme COX-2 in AVICs from control valves and stenotic valves (Fig. 3A) . Consistent with these results, PGE 2 , a major product of COX-2 activity, was detected in the supernatants of TLR3-activated
AVICs from control and stenotic valves (Fig. 3 , panels B-C). Later, we tested the expression of the adhesion molecule ICAM-1, previously described to be induced by LPS in AVICs [11] . TLR3-mediated induction of COX-2, PGE 2 and ICAM-1 expression was very robust and the kinetic showed a biphasic response (Fig. 3A) .
Moreover, the effect was not blocked by SN50, a NF-κB inhibitor that prevents NF-κB translocation into the nucleus (Fig. 3D) , suggesting that NF-κB complexes containing p50 protein are not involved in the response, but a sequence initiated by TRIF/IRF3 activation might play a role. These results suggest that AVICs exposed to agonists mimicking viral patterns activate TLR3-mediated and NF-κB-independent proinflammatory responses.
Engagement of TLR4, but not TLR2, induces NF-κB-dependent expression of proinflammatory molecules in AVICs from control and stenotic valves
Next, we evaluated the induction of pro-inflammatory molecules by bacterial patterns. Notably, LPS-mediated NF-κB activation was sustained and detectable 12-24 h after stimulation in AVICs from control and stenotic valves (Fig. 4A) , thus resembling 15 data observed upon TLR3-activation (Fig. 3A) . On the contrary, after TLR2 stimulation with Pam 3 CSK4, low or no activation was observed at late times (Fig. 4A ). In parallel with NF-κB activation, a TLR4 ligand, but not a TLR2 agonist, induced the expression of COX-2 and ICAM-1 in AVICs from control valves and stenotic valves (Fig. 4A) .
Consistent with these results, PGE 2 was detected in the supernatants of TLR4-activated
AVICs from control and stenotic valves (Fig. 4, panels B-C) . Moreover, a NF-κB inhibitor blocked the TLR4-mediated induction of COX-2 and ICAM-1 (Fig. 4D) , the gene of which is known to be regulated by NF-κB [16] . Together, data demonstrate that TLR4 activation promotes the long-lasting and NF-κB-dependent induction of COX-2
and ICAM-1 expression in human AVICs.
TLR3 and TLR4 engagement induce a similar profile of pro-inflammatory cytokines in AVICs
To compare the effect of TLR ligands on the production of other pro-inflammatory 
TLR3 and TLR4 ligands induce the activity of the calcification biomarker ALP
Since it has recently been described that LPS promotes a pro-osteogenic phenotype via TLR4 activation [13] , we tested whether a TLR3 ligand would induce ALP activity, a biomarker of early calcification, in human AVICs. Cells cultured with conditioning media showed some increase in ALP activity as compared with cells cultured in growth media, and LPS stimulation increased ALP activity further (Fig. 6 , panels A-B), consistent with a previous study [13] . Strikingly, poly (I:C) increased ALP expression in staining experiments (Fig. 6A) . Moreover, poly (I:C) significantly up-regulated ALP activity as compared to conditioning media (Fig. 6B) , and also increased calcified nodule formation (data not shown). Together, these data suggest that TLR3 activation induces in vitro calcification of human AVICs that could be relevant to the pathogenesis of aortic stenosis.
Discussion
The present study demonstrates that human AVICs express most of TLRs, which are differentially expressed in cells from non-stenotic and stenotic valves. Moreover, cell exposure to viral as well as Gram-negative bacteria patterns promotes TLR-mediated sustained inflammatory and pro-osteogenic responses, which could be relevant to the pathophysiology of degenerative aortic stenosis.
Our data is the first demonstration that human AVICs can sense viral as well as bacterial patterns. Our study confirms the reported expression of tlr4 and tlr2 genes in human AVICs [11] , and also demonstrates that these cells express all tlr genes, but tlr8, being tlr4 the most abundant gene, followed by tlr1, tlr6 and tlr3. The gene expression pattern is similar in AVICs from stenotic and control valve, although a differential expression was observed given the increase of TLR2 and TLR4 transcript levels, as recently described [13] , and the decrease of TLR5, and TLR9 levels in diseased valves as compared to control. At the protein level, our data suggest the existence of two populations of TLR4, being the cell-surface receptor levels lower than the ones internalized, in agreement with a report showing the predominant TLR4 cytosolic expression [11] . Even more, the total cellular TLR4 protein is higher in diseased valves, consistent with mRNA expression data and a recent report [13] , whereas the number of cell-surface receptors is similar in non-stenotic and stenotic valves. A plausible explanation is that internalized receptors may be ready to go to the cell surface, as part of a recycling process that could be up-regulated in diseased valves. Alternatively, TLR4-mediated NF-κB activation in AVICs [11] , and further demonstrate the involvement of NF-κB p50/p65 proteins in the TLR4-mediated induction of the expression of COX-2 and ICAM-1, the promoters of which contain NF-κB binding sites [16, 17] . Consistent with a specific role of TLR4 on long-lasting inflammatory responses, a specific ligand for TLR2/TLR1 induced NF-κB early activation, as previously reported [11] , but did not activate long-term responses. These findings differ from recent reports demonstrating TLR2-mediated release of cytokines and low induction of ICAM-1 in human AVICs [11, 13] . This discrepancy could be explained by the use of different TLR2 ligands, since peptidoglycan is a non-specific TLR2 ligand that can also bind to NOD receptors.
The present study is the first demonstration of a TLR-mediated induction of COX-2 in human AVICs exposed to some pathogen patterns. These findings would support the potential role of COX-2 inhibitors in preventing the development or delaying the progression of aortic stenosis. In this respect, the negative results of a randomized trial testing the effects of statins on aortic stenosis progression might be related to the fact that the same percentage of patients in the treated and the control groups were receiving aspirin, [18] , given that aspirin might have blocked inflammation in both groups, thus masking the putative protective effect of statins on stenosis progression. Our data suggest that TLR4-, but not TLR3-mediated induction of COX-2 is NF-κB-dependent, pointing out to a different transcriptional regulation. Interestingly, COX-2 induction has also been described in functionally related cells in other tissues, such as intestinal myofibroblasts [19] , and it has been associated to pulmonary fibrous disorders [20] .
Furthermore, our data show TLR4-mediated secretion of the COX-2 product, PGE 2 , a lipid mediator that could be involved in the inflammation underlying calcification of the 20 valves. In fact, PGE 2 has been reported to have potential to elevate expression of VEGF [21] , a pro-angiogenic and pro-inflammatory mediator that have been associated to aortic stenosis pathogenesis [1] . The production of PGE 2 has also been described in myofibroblasts from rat lungs [22] , and recent work suggests that LPS-induced PGE 2 secretion from intestinal myofibroblasts can exert paracrine effects on adjacent cells [19] .
Our data demonstrate the TLR3-and TLR4-mediated induction of ICAM-1, an adhesion molecule typically expressed in endothelial cells. Our data agree with reports demonstrating TLR4-mediated ICAM-1 induction [11, 23] , and further show the involvement of NF-κB-p50 protein, a transcription factor known to regulate icam-1 gene promoter [17] . Moreover, poly (I:C), which mimics a viral infection, strongly induces NF-κB-independent ICAM-1 expression in AVICs. Since poly (I:C) is known to induce adhesion molecules expression [24] , it is important to mention that cell cultures were free from endothelial contaminants that could account for ICAM-1 expression (data not shown). Furthermore, ICAM-1 might play an important role on myofibroblast function, since it has been described to be expressed in myofibroblastlike cells like such as hepatic stellate cells [25] . Interestingly, in a recent multi-ethnic study of atherosclerosis, soluble ICAM-1 was associated with increased prevalence and severity of aortic valve calcification [26] . One might speculate that the source of sICAM-1 can not only be endothelial cells, but also TLR-activated interstitial cells.
Consistent with the reported characteristic signalling cascades [5] , TLR4 activation promoted NF-κB-mediated pro-inflammatory responses, and TLR3 and TLR4 also induced NF-κB independent responses, most likely involving the TRIF/IRF-3 route as suggested by TLR3-and TLR4-mediated induction of IFN-in AVICs (data not shown). This is consistent with recent reports stressing the involvement of the TRIF 21 route in COX-2 induction in dendritic cells stimulated with Gram-positive bacteria [27] .
Our data also reveal the TLR3-and TLR4-mediated activation of the MAPK/p38, a proinflammatory kinase associated with both damaging and beneficial roles in the development of cardiovascular diseases [28] . Moreover, this kinase might be involved in the TLR-mediated inflammatory responses, since TLR3-and TLR4-mediated induction of pro-inflammatory molecules was blocked with a p38 inhibitor (data not shown). These findings are consistent with the reported role of p38 in the TLR4-mediated induction of COX-2 expression in murine intestinal myofibroblasts [19] .
Interestingly, the MAPK/ERK pathway has been associated to calcification of osteoblast precursors [15] , and AVICs from porcine origin [29] . Our data show ERK basal activation, suggesting that this pathway might be over-activated in human AVICs and poised to contribute to a pro-osteosteogenic phenotype. However, it cannot be ruled out that in vitro culture conditions might artificially activate ERK and JNK pathways, although under the same experimental conditions the stress MAPK/p38 is not basally activated.
Our data demonstrate that viral and bacterial patterns induce a strong proinflammatory phenotype in human AVICs. These cells constitutively express cytokines such IL-6 and IL-8, as described [30] , and also chemokines such as Gro, IL-8, MCP-1, and RANTES, and molecules involved in osteogenesis regulation, like OPG, TIMP1 and 2. Consistent with TLR-signalling data, TLR4 engagement, but not TLR2, promoted the expression of several chemokines, i.e., strong induction of IL-8, as described [30] , and also Gro and Groα, and a lower induction of MCP-1, and cytokines such as VEGF and OPG, known to be involved in osteogenesis regulation [2] .
Strikingly, TLR3 activation promotes a similar cytokine profile, even induced the expression of more cytokines than LPS, i.e., chemokines such as RANTES, GCP-2, and 
